FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to oncology and can be used for conservative effect on malignant tumours. The method involves effect on a malignant tumour by three components - radiation therapy and a cytostatic agent and a binary catalyst systems "oxycobalamin+ascorbic acid".
EFFECT: combined application of all components of the method allows improving antineoplastic effect due to intensified tumour growth inhibition ensured by synergetic action of the components, and also reducing therapeutic toxicity owing to lower doses of the radiation therapy and said cytostatic agent.
4 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR INHIBITION OF TUMOR GROWTH | 2003 |
|
RU2255742C2 |
SPECIFIC COMBINED THERAPY OF MALIGNANT TUMOURS WITH CYTOSTATIC AGENT AND ITS MODIFYING AGENT | 2015 |
|
RU2571551C1 |
ANTITUMORIGENESIS METHOD | 2007 |
|
RU2376999C2 |
METHOD FOR TREATING LUNG CANCER | 2017 |
|
RU2682293C2 |
METHOD OF OBTAINING OXYCOBALAMINE | 2008 |
|
RU2368618C1 |
OCTA-4,5-CARBOXYLIC ACID PHTHALOCYANINE COBALT ESTERS, THEIR INCLUSION COMPLEXES WITH BETA-CYCLODEXTRIN PROPYLENE GLYCOL ESTER AND METHOD OF SUPPRESSION OF TUMOR GROWTH | 2000 |
|
RU2172319C1 |
METHOD OF INTEGRATED TREATMENT OF LOCALLY ADVANCED MALIGNANT BRONCHIAL AND/OR TRACHEAL TUMOURS | 2008 |
|
RU2372119C1 |
METHOD FOR TUMOUR GROWTH INHIBITION | 2012 |
|
RU2491930C1 |
METHOD OF COMBINED THERAPY FOR CONNECTIVE TISSUE SARCOMA M-1 IN RATS USING A CONJUGATE OF DIPROPOXYBACTERIOPURPURIN WITH DOXORUBICIN | 2023 |
|
RU2808909C1 |
AGENT FOR PROPHYLAXIS DISEASES OF ONCOLOGICAL AND NON-ONCOLOGICAL PATTERN AND FOR CORRECTION OF HOMEOSTASIS DISTURBANCES | 2001 |
|
RU2208446C2 |
Authors
Dates
2010-06-27—Published
2008-11-10—Filed